Overview
Katherine Tarlock is a Hematologist and an Oncologist practicing medicine in Seattle, Washington.
Dr. Tarlock is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Childhood Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Leukemia, Acute Megakaryoblastic Leukemia, and Bone Marrow Transplant.
She is actively involved in clinical research, co-authoring 47 peer reviewed articles and participating in 2 clinical trials. Dr. Tarlock is currently accepting new patients.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
Locations
4800 Sand Point Way NE, Seattle, WA 98105
Additional Areas of Focus
Dr. Tarlock has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Seattle Children's Hospital
Douglas Hawkins is a Hematologist and an Oncologist practicing medicine in Seattle, Washington. Dr. Hawkins is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Rhabdomyosarcoma, Adult Soft Tissue Sarcoma, Osteosarcoma, Osteotomy, and Bone Marrow Aspiration. Dr. Hawkins is currently accepting new patients.
Seattle Children's Hospital
Sarah Leary is a Hematologist and an Oncologist practicing medicine in Seattle, Washington. Dr. Leary is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Medulloblastoma, Glioma, Gliomatosis Cerebri, Brain Tumor, and Bone Marrow Aspiration. Dr. Leary is currently accepting new patients.
Gme Office University Of Washington
Soheil Meshinchi is a Hematologist and an Oncologist practicing medicine in Seattle, Washington. Dr. Meshinchi is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Childhood Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute Megakaryoblastic Leukemia, Leukemia, and Bone Marrow Transplant. Dr. Meshinchi is currently accepting new patients.
Frequently Asked Questions about Dr. Katherine G. Tarlock
How do I make an appointment with Dr. Katherine G. Tarlock?
You can book an appointment with Dr. Katherine G. Tarlock by calling their office at 206-987-2106. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Katherine G. Tarlock a top-rated expert for Childhood Acute Myeloid Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Katherine G. Tarlock is classified as an Distinguished expert for Childhood Acute Myeloid Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Katherine G. Tarlock specialize in?
While Dr. Katherine G. Tarlock is a Hematology, they have specific expertise in Childhood Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), and Leukemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Katherine G. Tarlock participate in research or clinical trials?
Yes. Dr. Katherine G. Tarlock has published 47 articles and abstracts on conditions like Childhood Acute Myeloid Leukemia. You can view a list of Dr. Katherine G. Tarlock's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Katherine G. Tarlock accept my insurance?
Dr. Katherine G. Tarlock accepts most major insurance plans, including Aetna and Community Health. We recommend calling the office directly at 206-987-2106 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloid Leukemia (AML)Dr. Tarlock isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Childhood Acute Myeloid LeukemiaDr. Tarlock isDistinguished. Learn about Childhood Acute Myeloid Leukemia.
- LeukemiaDr. Tarlock isDistinguished. Learn about Leukemia.
- Advanced
- Acute Megakaryoblastic LeukemiaDr. Tarlock isAdvanced. Learn about Acute Megakaryoblastic Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Tarlock isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Bone Marrow TransplantDr. Tarlock isExperienced. Learn about Bone Marrow Transplant.
- HistiocytosisDr. Tarlock isExperienced. Learn about Histiocytosis.
- Multicentric ReticulohistiocytosisDr. Tarlock isExperienced. Learn about Multicentric Reticulohistiocytosis.
- Myelodysplastic Syndrome (MDS)Dr. Tarlock isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Non-Langerhans-Cell HistiocytosisDr. Tarlock isExperienced. Learn about Non-Langerhans-Cell Histiocytosis.
- ReticulohistiocytomaDr. Tarlock isExperienced. Learn about Reticulohistiocytoma.
- Rosai-Dorfman DiseaseDr. Tarlock isExperienced. Learn about Rosai-Dorfman Disease.
- Sea-Blue HistiocytosisDr. Tarlock isExperienced. Learn about Sea-Blue Histiocytosis.